Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 2
1979 1
1986 2
1990 1
1991 1
1992 1
1996 3
1998 3
1999 1
2000 1
2001 1
2002 3
2003 5
2004 1
2006 4
2007 4
2008 6
2009 4
2010 3
2011 3
2012 6
2013 4
2014 5
2015 5
2016 5
2017 3
2018 4
2019 9
2020 7
2021 10
2022 9
2023 13
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Escape Beyond Mid-Chin"
Page 1
Effect of Physical Therapy vs Arthroscopic Partial Meniscectomy in People With Degenerative Meniscal Tears: Five-Year Follow-up of the ESCAPE Randomized Clinical Trial.
Noorduyn JCA, van de Graaf VA, Willigenburg NW, Scholten-Peeters GGM, Kret EJ, van Dijk RA, Buchbinder R, Hawker GA, Coppieters MW, Poolman RW; ESCAPE Research Group. Noorduyn JCA, et al. JAMA Netw Open. 2022 Jul 1;5(7):e2220394. doi: 10.1001/jamanetworkopen.2022.20394. JAMA Netw Open. 2022. PMID: 35802374 Free PMC article. Clinical Trial.
IMPORTANCE: There is a paucity of high-quality evidence about the long-term effects (ie, 3-5 years and beyond) of arthroscopic partial meniscectomy vs exercise-based physical therapy for patients with degenerative meniscal tears. ...
IMPORTANCE: There is a paucity of high-quality evidence about the long-term effects (ie, 3-5 years and beyond) of arthroscopic partia …
Extracranial-Intracranial Bypass and Risk of Stroke and Death in Patients With Symptomatic Artery Occlusion: The CMOSS Randomized Clinical Trial.
Ma Y, Wang T, Wang H, Amin-Hanjani S, Tong X, Wang J, Tong Z, Kuai D, Cai Y, Ren J, Wang D, Duan L, Maimaitili A, Hang C, Yu J, Bai X, Powers WJ, Derdeyn CP, Wu Y, Ling F, Gu Y, Jiao L; CMOSS Investigators. Ma Y, et al. JAMA. 2023 Aug 22;330(8):704-714. doi: 10.1001/jama.2023.13390. JAMA. 2023. PMID: 37606672 Free PMC article. Clinical Trial.
MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of stroke or death within 30 days or ipsilateral ischemic stroke beyond 30 days through 2 years after randomization. There were 9 secondary outcomes, including any stroke or death within 2 years and fatal stro …
MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of stroke or death within 30 days or ipsilateral ischemic stroke beyond …
Benefits and Harms of Digital Health Interventions Promoting Physical Activity in People With Chronic Conditions: Systematic Review and Meta-Analysis.
Zangger G, Bricca A, Liaghat B, Juhl CB, Mortensen SR, Andersen RM, Damsted C, Hamborg TG, Ried-Larsen M, Tang LH, Thygesen LC, Skou ST. Zangger G, et al. J Med Internet Res. 2023 Jul 6;25:e46439. doi: 10.2196/46439. J Med Internet Res. 2023. PMID: 37410534 Free PMC article. Review.
Future studies should focus on better reporting, comparing the effects of different digital health solutions, and investigating how intervention effects are sustained beyond the end of the intervention. TRIAL REGISTRATION: PROSPERO CRD42020189028; https://www.crd.york.ac.u …
Future studies should focus on better reporting, comparing the effects of different digital health solutions, and investigating how interven …
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, Hinsley W, Bernal JL, Kall M, Bhatt S, Blomquist P, Zaidi A, Volz E, Aziz NA, Harman K, Funk S, Abbott S; COVID-19 Genomics UK (COG-UK) consortium; Hope R, Charlett A, Chand M, Ghani AC, Seaman SR, Dabrera G, De Angelis D, Presanis AM, Thelwall S. Nyberg T, et al. Lancet. 2022 Apr 2;399(10332):1303-1312. doi: 10.1016/S0140-6736(22)00462-7. Epub 2022 Mar 16. Lancet. 2022. PMID: 35305296 Free PMC article.
BACKGROUND: The omicron variant (B.1.1.529) of SARS-CoV-2 has demonstrated partial vaccine escape and high transmissibility, with early studies indicating lower severity of infection than that of the delta variant (B.1.617.2). ...In vaccinated cases, past infection offered …
BACKGROUND: The omicron variant (B.1.1.529) of SARS-CoV-2 has demonstrated partial vaccine escape and high transmissibility, with ear …
The MEK5/ERK5 Pathway in Health and Disease.
Paudel R, Fusi L, Schmidt M. Paudel R, et al. Int J Mol Sci. 2021 Jul 15;22(14):7594. doi: 10.3390/ijms22147594. Int J Mol Sci. 2021. PMID: 34299213 Free PMC article. Review.
However, it also maintains integrity in other tissues exposed to mechanical stress, including bone, cartilage, and muscle, where it exerts a key function as a survival and differentiation pathway. Beyond its diverse physiological roles, the MEK5/ERK5 pathway has also been …
However, it also maintains integrity in other tissues exposed to mechanical stress, including bone, cartilage, and muscle, where it exerts a …
Tocilizumab for giant cell arteritis.
Antonio AA, Santos RN, Abariga SA. Antonio AA, et al. Cochrane Database Syst Rev. 2022 May 13;5(5):CD013484. doi: 10.1002/14651858.CD013484.pub3. Cochrane Database Syst Rev. 2022. PMID: 35560150 Free PMC article. Review.
Findings One RCT (30 participants) compared tocilizumab administered every four weeks versus placebo. Point estimates at 12 months and beyond favored tocilizumab over placebo in terms of sustained remission (risk ratio (RR) 4.25, 95% confidence interval (CI) 1.21 to 14.88; …
Findings One RCT (30 participants) compared tocilizumab administered every four weeks versus placebo. Point estimates at 12 months and be …
Tocilizumab for giant cell arteritis.
Antonio AA, Santos RN, Abariga SA. Antonio AA, et al. Cochrane Database Syst Rev. 2021 Aug 22;8(8):CD013484. doi: 10.1002/14651858.CD013484.pub2. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 13;5:CD013484. doi: 10.1002/14651858.CD013484.pub3. PMID: 34420204 Free PMC article. Updated. Review.
Findings One RCT (30 participants) compared tocilizumab administered every four weeks versus placebo. Point estimates at 12 months and beyond favored tocilizumab over placebo in terms of sustained remission (risk ratio (RR) 4.25, 95% confidence interval (CI) 1.21 to 14.88; …
Findings One RCT (30 participants) compared tocilizumab administered every four weeks versus placebo. Point estimates at 12 months and be …
The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence.
Cerreto M, Cardone F, Cerrito L, Stella L, Santopaolo F, Pallozzi M, Gasbarrini A, Ponziani FR. Cerreto M, et al. Curr Oncol. 2023 Sep 26;30(10):8774-8792. doi: 10.3390/curroncol30100633. Curr Oncol. 2023. PMID: 37887533 Free PMC article. Review.
This explains the urge to find new systemic treatments that can improve the survival and quality of life in patients that can go beyond the first line of treatment. The aim of this paper is to offer a complete overview of the most recent innovations in systemic treatments …
This explains the urge to find new systemic treatments that can improve the survival and quality of life in patients that can go beyond …
Intergenerational Interdependence of Labour Market Careers.
Brydsten A, Baranowska-Rataj A. Brydsten A, et al. Adv Life Course Res. 2022 Dec;54:100513. doi: 10.1016/j.alcr.2022.100513. Epub 2022 Sep 6. Adv Life Course Res. 2022. PMID: 36651620
However, little is known about the intergenerational transmission for those who manage to escape from precariousness, and how the transmission of labour market disadvantage operates depending on the gender structure of parent-child dyads. ...We also show that the mother's …
However, little is known about the intergenerational transmission for those who manage to escape from precariousness, and how the tra …
Unveiling the veil of lactate in tumor-associated macrophages: a successful strategy for immunometabolic therapy.
Tao H, Zhong X, Zeng A, Song L. Tao H, et al. Front Immunol. 2023 Jul 26;14:1208870. doi: 10.3389/fimmu.2023.1208870. eCollection 2023. Front Immunol. 2023. PMID: 37564659 Free PMC article. Review.
Lactate, traditionally regarded as a metabolic waste product at the terminal of the glycolysis process, has recently been found to have multifaceted functional roles in metabolism and beyond. A metabolic reprogramming phenomenon commonly seen in tumor cells, known as the " …
Lactate, traditionally regarded as a metabolic waste product at the terminal of the glycolysis process, has recently been found to have mult …
122 results